Profile data is unavailable for this security.
About the company
Advanced Oncotherapy Plc is a United Kingdom-based specialist developer and provider of a proton therapy system, the LIGHT system. The Company’s team, ADAM, based in Geneva, is focused on the development of a proprietary proton accelerator called, Linac Image Guided Hadron Technology (LIGHT). LIGHT's compact configuration delivers proton beams in a way that facilitates greater precision and electronic control. The linear design of LIGHT allows for active longitudinal modulation along the proton beam axis and the variation of the proton beam by electronic means during cancer treatment. The modular feature of LIGHT offers hospitals and treatment centers the flexibility to customize cancer treatment plans based on a range of energies. Its subsidiaries include ADAM S.A., Advanced Oncotherapy Americas Inc, Advanced Oncotherapy B.V., Advanced Oncotherapy Resources Ltd, APTS Harley Street Ltd, Advanced Oncotherapy (China) Ltd, Advanced Oncotherapy Proton Therapy Services Ltd and other.
- Revenue in GBP (TTM)0.00
- Net income in GBP-32.60m
- Incorporated2005
- Employees174.00
- LocationAdvanced Oncotherapy PLCThird Fl, 4 Tenterden StreetLONDON W1S 1TEUnited KingdomGBR
- Phone+44 203 617 8728
- Websitehttps://www.avoplc.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deltex Medical Group plc | 1.78m | -1.28m | 2.37m | 37.00 | -- | 0.7018 | -- | 1.33 | -0.0012 | -0.0012 | 0.0015 | 0.0018 | 0.2974 | 0.8471 | 5.61 | 48,000.00 | -21.47 | -14.66 | -29.13 | -21.81 | 63.34 | 71.84 | -72.18 | -32.93 | 1.13 | -2.98 | 0.3793 | -- | -28.44 | -18.55 | -11.97 | -- | 9.78 | -- |
| Truspine Technologies PLC | 0.00 | -471.89k | 2.37m | 1.00 | -- | 0.831 | -- | -- | -0.004 | -0.004 | 0.00 | 0.0205 | 0.00 | -- | -- | 0.00 | -13.14 | -21.97 | -16.58 | -26.49 | -- | -- | -- | -- | -- | -32.31 | 0.0984 | -- | -- | -- | 23.29 | -- | 21.72 | -- |
| Surgical Innovations Group Plc | 12.01m | -509.00k | 4.66m | 90.00 | -- | 0.4449 | 18.81 | 0.3882 | -0.0005 | -0.0005 | 0.0129 | 0.0112 | 0.8032 | 2.85 | 5.89 | -- | -3.40 | -8.19 | -4.18 | -9.94 | 28.70 | 32.51 | -4.24 | -13.31 | 1.23 | -4.45 | 0.1368 | -- | 5.94 | 1.84 | -292.80 | -- | 7.20 | -- |
| Myhealthchecked PLC | 14.95m | 189.00k | 5.20m | 15.00 | 26.95 | 0.6083 | 15.71 | 0.348 | 0.0037 | 0.0037 | 0.2885 | 0.1644 | 1.26 | 5.81 | 7.95 | 996,400.00 | 1.59 | -20.09 | 2.21 | -28.23 | 27.79 | 22.62 | 1.26 | -13.42 | 3.53 | -- | 0.0047 | -- | 36.26 | 190.36 | -24.30 | -- | -12.80 | -- |
| Rua Life Sciences PLC | 1.87m | -1.87m | 6.90m | 40.00 | -- | 0.661 | -- | 3.69 | -0.0843 | -0.0843 | 0.0843 | 0.1683 | 0.3293 | 3.26 | 4.80 | 46,725.00 | -32.95 | -25.97 | -36.33 | -28.26 | 81.97 | -- | -100.05 | -110.53 | 2.40 | -61.71 | 0.1065 | -- | 34.09 | 40.08 | 3.10 | -- | 94.82 | -- |
| Advanced Oncotherapy PLC | 0.00 | -32.60m | 9.50m | 174.00 | -- | 0.1306 | -- | -- | -0.0819 | -0.0819 | 0.00 | 0.134 | 0.00 | 0.00 | -- | 0.00 | -23.34 | -25.83 | -29.05 | -30.15 | -- | -- | -- | -- | 0.1293 | -4.06 | 0.4968 | -- | -- | -- | -16.57 | -- | -0.8064 | -- |
| Inspiration Healthcare Group PLC | 41.08m | -550.00k | 11.43m | 210.00 | -- | 0.3245 | 6.79 | 0.2782 | -0.0081 | -0.0081 | 0.603 | 0.5163 | 0.7879 | 2.32 | 4.76 | 195,619.00 | -1.05 | 6.14 | -1.25 | 7.60 | 45.59 | 47.42 | -1.34 | 6.00 | 1.50 | -0.1289 | 0.2317 | -- | 0.4458 | 21.62 | -93.58 | -25.97 | 52.54 | -- |
| Ondine Biomedical Inc | 469.32k | -10.92m | 11.61m | 43.00 | -- | 4.15 | -- | 24.75 | -0.0561 | -0.0561 | 0.0024 | 0.0124 | 0.0492 | 0.3584 | 5.54 | 10,914.43 | -114.33 | -- | -135.98 | -- | 49.00 | -- | -2,326.12 | -- | 1.93 | -- | 0.1961 | -- | -75.17 | -- | 61.32 | -- | -- | -- |
| Belluscura PLC | 959.67k | -7.98m | 12.37m | 24.00 | -- | 0.5057 | -- | 12.89 | -0.0645 | -0.0645 | 0.0078 | 0.1482 | 0.0445 | 0.2197 | 0.3099 | 39,986.12 | -36.98 | -35.98 | -40.59 | -39.17 | -32.24 | -40.01 | -831.69 | -838.02 | 4.17 | -3.43 | 0.00 | -- | 232.62 | 31.09 | -56.38 | -- | 30.90 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Odey Asset Management LLPas of 28 Jun 2023 | 40.47m | 0.00% |
| eQ Varainhoito Oyas of 10 May 2023 | 15.63m | 0.00% |
| Chaussier Gestion SAas of 28 Mar 2024 | 400.00k | 0.00% |
| Brompton Asset Management LLPas of 30 Jun 2023 | 0.00 | 0.00% |
| Belgrave Capital Management Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
| DNCA Finance SAas of 30 Jun 2023 | 0.00 | 0.00% |
